tacrolimus Articles
Japanese stock commentary - Nov 3
10 November 2003
Promising data for Fujisawa's FK778
6 October 2003
Tokyo pharma stocks - week to Sept 29
6 October 2003
Tokyo pharma stocks - week to August 4
11 August 2003
Stock Commentary - Tokyo
28 July 2003
Tokyo pharma stocks - week to July 21
28 July 2003
Tokyo pharma stocks - week to June 9
16 June 2003
Neoral improves donor kidneys' survival
16 June 2003
Fujisawa and GSK in co-promotion deal
9 June 2003
Tokyo stocks to April 28
5 May 2003
Fujisawa to write off investment losses
28 April 2003
UK NICE to view statins, antipsychotics, etc
7 April 2003
Fujisawa set to post 17% profit increase
17 March 2003
Fujisawa files for new antifungal in Europe
3 March 2003
Tokyo pharma stocks - week to August 12
19 August 2002
Tacrolimus ointment in infant eczema assessed
12 August 2002
Tokyo pharma stocks - week to July 8
15 July 2002
New data on Novartis transplant drugs
6 May 2002
Tokyo pharma stocks - week to April 29
6 May 2002
Protopic launched in first Euro market
22 April 2002
Tokyo pharma stocks - week to March 25
1 April 2002
Tokyo pharma stocks - week to March 18
25 March 2002
Fujisawa's Protopic cleared in EU
18 March 2002
Tokyo stocks to March 11
18 March 2002
Fujisawa's tacrolimus in Phase III for IBD
11 March 2002
Tokyo pharma stocks - week to March 4
11 March 2002
Tokyo pharma stocks - week to February 25
4 March 2002
Sucampo licenses tacrolimus for ophthalmic uses
25 February 2002
Tokyo pharma stocks - week to January 21
28 January 2002
Tokyo pharma stocks - week to January 14.
21 January 2002
Tokyo pharma stocks - week to January 7
14 January 2002
JOMED licenses rights to tacrolimus-coated stent
7 January 2002
JOMED licenses rights to tacrolimus-coated stent
24 December 2001
Tokyo pharma stocks - week to December 10
11 December 2001
Fujisawa sales soar in North America
12 November 2001
Stock Commentary - Tokyo
1 November 2001
Tokyo pharma stocks - week to October 29
30 October 2001
Protopic backed for atopic dermatitis in EU
25 October 2001
Fujisawa launches Protopic Ointment
11 October 2001
Japan pharma stocks - week to October 8
9 October 2001
Japan pharma stocks - week to October 1
3 October 2001
Stock Commentary - Tokyo
19 July 2001
Japan pharma stocks - week to July 16
18 July 2001
Fujisawa licenses transplant drugs from Aventis
13 July 2001
Japan pharma stocks - week to July 9
11 July 2001
Japan pharma stock market week to May 21
23 May 2001
Tokyo pharma stock market to May 7, 2001
8 May 2001
Tokyo pharma stock market: week to April 9, 2001
10 April 2001
Stock Commentary - Tokyo
1 March 2001
Fujisawa's Protopic launched in USA
26 February 2001
Stock Commentary - Tokyo
14 December 2000
Protopic cleared by FDA for eczema
13 December 2000
Fujisawa's Protopic backed in USA
22 November 2000
Prograf driving Fujisawa sales
13 November 2000
Fujisawa drops migraine compound
5 October 2000
Atopic dermatitis world market forecasts
14 September 2000
BTI's transplant product shows promise
31 August 2000
Fujisawa seeks Europe OK for Protopic
22 August 2000
Stock Commentary Tokyo
3 August 2000
Fujisawa sees delay in Protopic review
27 July 2000
Fujisawa fiscal 1999 turnover driven by Prograf
24 May 2000
New $76 million bulk tacrolimus plant for Fujisawa
26 April 2000
Fujisawa to invest $59M in FK 463 plant
7 March 2000
Stock Commentary Tokyo
2 March 2000
Fujisawa to construct new formulation facilities for Protopic
24 February 2000
Fujisawa to base international strategy on Prograf
28 January 2000
Stock Commentary Tokyo
2 December 1999
Fujisawa launches Protopic
29 November 1999
Stock Commentary Tokyo
18 November 1999
FDA accepts tacrolimus file for atopic dermatitis
16 November 1999
Fujisawa earnings driven by Prograf; pipeline looking healthy
15 November 1999
Stock Commentary Tokyo
4 November 1999
Fujisawa lifts FY 2000 earnings forecasts
1 November 1999
Fujisawa files NDA for topical tacrolimus
22 September 1999
AHP weathers the storm with first Rapamune approval
17 September 1999
2000 set to be a dramatic year for Japan's drug industry says Lehman
2 September 1999
Fujisawa delays Protopic launch
13 August 1999
Fujisawa expanding tacrolimus indications
10 August 1999
Stock Commentary Tokyo
29 July 1999
Stock Commentary Tokyo
22 July 1999
Stock Commentary Tokyo
1 July 1999
Stock Commentary Tokyo
22 April 1999
Stock Commentary Tokyo
29 March 1999
Fujisawa increases reps in USA and Europe
22 January 1999
Prograf turned down for bone marrow transplants
13 January 1999
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
